New Therapies to Help Stroke Survivors Recover Language Years After InjuryNearly 20% of stroke victims are under 55, compared with fewer than 13% in the early 1990s, according to a 2012 study in the journal Neurology.Laura Landrohttps://www.facebook.com/wsj...
“But if possible, I would recommend to patients that they choose a hospital like UVA that offers all available stroke therapies.” “The interdisciplinary team of emergency medicine, stroke neurology, neurointerventional surgery, neurosurgery and neuro-critical care at UVA is unique to our region ...
M. Optogenetic and chemogenetic therapies for epilepsy. Neuropharmacology 168, 107751 (2020). Article CAS PubMed Google Scholar Sahel, J. A. et al. Partial recovery of visual function in a blind patient after optogenetic therapy. Nat. Med. 27, 1223–1229 (2021). Article CAS PubMed Google...
An absence of effective therapies may be one of the reasons for this lack of interest; the costs have been taken as inevitable. With the advent of new therapies for acute ischaemic stroke (thrombolytics and neuroprotectants) there is renewed interest in improving both the management and outcome...
The newest research has found benefits forhypertension, neo-natal and pediatric care, spinal cord injury and Long COVID Syndrome.A recently published study from the Cleveland Clinic shows that integrative therapies that include massage therapy, canimprove the physical, mental and social healthfor ...
Traumatic brain injury (TBI) results in a significant amount of cell death in the brain. Unfortunately, the adult mammalian brain possesses little regenerative potential following injury and little can be done to reverse the initial brain damage caused b
Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Unlike nutraceutical and pharmaceutical interventions that showed controversial results in sarcopenia ...
Clearly, therapeutic MMP inhibition in acute brain injury and stroke has considerable potential based on available mouse and human data. However, the difficulty will again be to avoid adverse effects of MMP inhibi- tion, especially during stages of recovery. Therefore, detailed analyses of both ...
“Despite its daily impact on the lives of patients, there are currently no approved therapies for mild-to-moderate HS and the current standard of care is often inadequate. Today’s data represent an important step in progressing research for HS with the goal of being able to provide patients...
impairment in settings where advanced testing is limited,” the researchers wrote in their study. “Therefore, use of a blood biomarker is intended to enhance an early and precise AD diagnosis, leading to improved patient management and, ultimately, timely access to disease-modifying therapies.” ...